{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-4493"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-4493","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"DEVELOPMENT OF AN ENSEMBLE BIOSENSOR FOR FATTY ACIDS AND ENHANCING THE ANTIBIOTIC PROPERTIES OF MEROPENEM WITH HYDROPHOBIC ION PARING AND NSF NATIONAL I-CORPS EXPERIENCE AND COMMERCIALIZATION ROADMAP FOR THE PAPER BASED ENSEMBLE BIOSENSOR FOR IBS","abstract":"This thesis integrates three interconnected studies focused on advancing biomedical diagnostics and therapeutic formulation. Primary task was developing an ensemble biosensor for multiplex fatty acid detection using protein - fluorophore interactions. A fluorescence matrix of BSA and FABP with 1,8-ANS, 2-AC, and fluorescein differentiated eight fatty acids with 94.59% accuracy. Validation in H. pylori positive stool samples confirmed its sensitivity and specificity with potentiality as a non-invasive diagnostic platform for Gastrointestinal and chronic diseases. The second project explores Hydrophobic Ion Pairing (HIP) to enhance the lipophilicity and bioactivity of the β-lactam antibiotic meropenem. HIP complexes with hydrophobic counter-ions improved stability, membrane permeability, and antimicrobial efficacy, offering a scalable strategy to combat antibiotic resistance. The third component, developed under the NSF I-Corps Program, translated the ensemble biosensor into a market-ready paper-based platform for point-of-care IBS diagnostics. Through extensive stakeholder interviews and iterative business modeling, the work bridges laboratory innovation with real-world application, demonstrating a unified approach to diagnostic development and translational science.","abstract_html":"This thesis integrates three interconnected studies focused on advancing biomedical diagnostics and therapeutic formulation. Primary task was developing an ensemble biosensor for multiplex fatty acid detection using protein - fluorophore interactions. A fluorescence matrix of BSA and FABP with 1,8-ANS, 2-AC, and fluorescein differentiated eight fatty acids with 94.59% accuracy. Validation in H. pylori positive stool samples confirmed its sensitivity and specificity with potentiality as a non-invasive diagnostic platform for Gastrointestinal and chronic diseases. The second project explores Hydrophobic Ion Pairing (HIP) to enhance the lipophilicity and bioactivity of the β-lactam antibiotic meropenem. HIP complexes with hydrophobic counter-ions improved stability, membrane permeability, and antimicrobial efficacy, offering a scalable strategy to combat antibiotic resistance. The third component, developed under the NSF I-Corps Program, translated the ensemble biosensor into a market-ready paper-based platform for point-of-care IBS diagnostics. Through extensive stakeholder interviews and iterative business modeling, the work bridges laboratory innovation with real-world application, demonstrating a unified approach to diagnostic development and translational science.","abstract_has_math":false,"creators":["Paul, Krishna"],"institution":null,"degree_name":"M.S. Pharmaceutical Sciences","degree_level":"Thesis","degree_discipline":"Chemistry and Biochemistry","degree_department":null,"school":null,"contributors":["Lark J Perez, Ph.D.","Subash Jonnalagadda, Ph.D.","Thomas Keck, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T09:00:05Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/3487","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/3487","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-4493","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Lark J Perez, Ph.D.","Subash Jonnalagadda, Ph.D.","Thomas Keck, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Paul, Krishna"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2026-02-25T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2026-02-25T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry and Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S. Pharmaceutical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/3487"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["This thesis integrates three interconnected studies focused on advancing biomedical diagnostics and therapeutic formulation. Primary task was developing an ensemble biosensor for multiplex fatty acid detection using protein - fluorophore interactions. A fluorescence matrix of BSA and FABP with 1,8-ANS, 2-AC, and fluorescein differentiated eight fatty acids with 94.59% accuracy. Validation in H. pylori positive stool samples confirmed its sensitivity and specificity with potentiality as a non-invasive diagnostic platform for Gastrointestinal and chronic diseases. The second project explores Hydrophobic Ion Pairing (HIP) to enhance the lipophilicity and bioactivity of the β-lactam antibiotic meropenem. HIP complexes with hydrophobic counter-ions improved stability, membrane permeability, and antimicrobial efficacy, offering a scalable strategy to combat antibiotic resistance. The third component, developed under the NSF I-Corps Program, translated the ensemble biosensor into a market-ready paper-based platform for point-of-care IBS diagnostics. Through extensive stakeholder interviews and iterative business modeling, the work bridges laboratory innovation with real-world application, demonstrating a unified approach to diagnostic development and translational science."]},{"key":"dc:title","label":"Title","values":["DEVELOPMENT OF AN ENSEMBLE BIOSENSOR FOR FATTY ACIDS AND ENHANCING THE ANTIBIOTIC PROPERTIES OF MEROPENEM WITH HYDROPHOBIC ION PARING AND NSF NATIONAL I-CORPS EXPERIENCE AND COMMERCIALIZATION ROADMAP FOR THE PAPER BASED ENSEMBLE BIOSENSOR FOR IBS"]}]}],"canonical_facts":{"dc:contributor":["Lark J Perez, Ph.D.","Subash Jonnalagadda, Ph.D.","Thomas Keck, Ph.D."],"dc:creator":["Paul, Krishna"],"dc:date.available":["2026-02-25T08:00:00Z"],"dc:date.created":["2026-02-25T08:00:00Z"],"dc:description.abstract":["This thesis integrates three interconnected studies focused on advancing biomedical diagnostics and therapeutic formulation. Primary task was developing an ensemble biosensor for multiplex fatty acid detection using protein - fluorophore interactions. A fluorescence matrix of BSA and FABP with 1,8-ANS, 2-AC, and fluorescein differentiated eight fatty acids with 94.59% accuracy. Validation in H. pylori positive stool samples confirmed its sensitivity and specificity with potentiality as a non-invasive diagnostic platform for Gastrointestinal and chronic diseases. The second project explores Hydrophobic Ion Pairing (HIP) to enhance the lipophilicity and bioactivity of the β-lactam antibiotic meropenem. HIP complexes with hydrophobic counter-ions improved stability, membrane permeability, and antimicrobial efficacy, offering a scalable strategy to combat antibiotic resistance. The third component, developed under the NSF I-Corps Program, translated the ensemble biosensor into a market-ready paper-based platform for point-of-care IBS diagnostics. Through extensive stakeholder interviews and iterative business modeling, the work bridges laboratory innovation with real-world application, demonstrating a unified approach to diagnostic development and translational science."],"dc:identifier":["https://rdw.rowan.edu/etd/3487"],"dc:title":["DEVELOPMENT OF AN ENSEMBLE BIOSENSOR FOR FATTY ACIDS AND ENHANCING THE ANTIBIOTIC PROPERTIES OF MEROPENEM WITH HYDROPHOBIC ION PARING AND NSF NATIONAL I-CORPS EXPERIENCE AND COMMERCIALIZATION ROADMAP FOR THE PAPER BASED ENSEMBLE BIOSENSOR FOR IBS"],"thesis:degree_discipline":["Chemistry and Biochemistry"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["M.S. Pharmaceutical Sciences"]},"updated_at":"2026-11-19T09:00:05Z"}